id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT00862433
|
8:19:treatment,32:56:treatment,58:81:treatment
|
Use of medications (other than oral hypoglycemic agents, hormonal contraceptives and medications taken only on an as-needed basis)
| 1
|
[
"Use",
"of",
"medications",
"(",
"other",
"than",
"oral",
"hypoglycemic",
"agents",
",",
"hormonal",
"contraceptives",
"and",
"medications",
"taken",
"only",
"on",
"an",
"as-needed",
"basis",
")"
] |
[
0,
0,
1,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01269034
|
5:20:chronic_disease
|
Any chronic disease
| 1
|
[
"Any",
"chronic",
"disease"
] |
[
0,
2,
2
] |
NCT02556606
|
22:57:chronic_disease,61:76:chronic_disease,78:93:chronic_disease,97:113:chronic_disease
|
Current diagnosis of obsessive-compulsive disorder (OCD) or eating disorder [bulimia nervosa or anorexia nervosa]
| 1
|
[
"Current",
"diagnosis",
"of",
"obsessive-compulsive",
"disorder",
"(",
"OCD",
")",
"or",
"eating",
"disorder",
"[",
"bulimia",
"nervosa",
"or",
"anorexia",
"nervosa",
"]"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0
] |
NCT01793519
|
,,,71:80:treatment,93:103:treatment,105:115:treatment,120:130:treatment,,170:182:treatment,184:202:treatment,204:217:treatment,219:230:treatment,232:243:treatment,245:257:treatment,259:271:treatment,279:292:treatment,,,,,,,
|
In sustained clinical remission for the last 6 months while receiving treatment with either etanercept, infliximab, or adalimumab, and greater than or equal to 1 DMARD (methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, minocycline, cyclosporine, azathioprine, gold, penicillamine). DAS28 should be less than 2.6 on each visit over the preceding 6 months, with at least one visit 2-4 months before enrollment. If there is no visit 6 months before enrollment, the nearest visit in the 6-12 month period before enrollment should be considered and have a DAS28 less than 2.6
| 1
|
[
"In",
"sustained",
"clinical",
"remission",
"for",
"the",
"last",
"6",
"months",
"while",
"receiving",
"treatment",
"with",
"either",
"etanercept",
",",
"infliximab",
",",
"or",
"adalimumab",
",",
"and",
"greater",
"than",
"or",
"equal",
"to",
"1",
"DMARD",
"(",
"methotrexate",
",",
"hydroxychloroquine",
",",
"sulfasalazine",
",",
"leflunomide",
",",
"minocycline",
",",
"cyclosporine",
",",
"azathioprine",
",",
"gold",
",",
"penicillamine",
")",
".",
"DAS28",
"should",
"be",
"less",
"than",
"2.6",
"on",
"each",
"visit",
"over",
"the",
"preceding",
"6",
"months",
",",
"with",
"at",
"least",
"one",
"visit",
"2-4",
"months",
"before",
"enrollment",
".",
"If",
"there",
"is",
"no",
"visit",
"6",
"months",
"before",
"enrollment",
",",
"the",
"nearest",
"visit",
"in",
"the",
"6-12",
"month",
"period",
"before",
"enrollment",
"should",
"be",
"considered",
"and",
"have",
"a",
"DAS28",
"less",
"than",
"2.6"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01884740
|
1:11:treatment,42:51:treatment,,114:124:treatment
|
craniotomy patients are eligible for the treatment if they have had a craniotomy greater than two weeks prior to IA therapy
| 1
|
[
"craniotomy",
"patients",
"are",
"eligible",
"for",
"the",
"treatment",
"if",
"they",
"have",
"had",
"a",
"craniotomy",
"greater",
"than",
"two",
"weeks",
"prior",
"to",
"IA",
"therapy"
] |
[
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02138617
|
1:25:treatment,27:38:treatment,55:71:chronic_disease,,105:137:treatment,166:190:treatment
|
Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to Day 1 of FOLFIRI + bevacizumab initiation or anticipation of need for major surgical procedure during the course of the study
| 1
|
[
"Major",
"surgical",
"procedure",
",",
"open",
"biopsy",
",",
"or",
"significant",
"traumatic",
"injury",
"within",
"28",
"days",
"prior",
"to",
"Day",
"1",
"of",
"FOLFIRI",
"+",
"bevacizumab",
"initiation",
"or",
"anticipation",
"of",
"need",
"for",
"major",
"surgical",
"procedure",
"during",
"the",
"course",
"of",
"the",
"study"
] |
[
1,
1,
1,
0,
1,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02310464
|
38:59:chronic_disease,81:98:chronic_disease,112:136:chronic_disease,,,147:171:chronic_disease,173:191:chronic_disease,196:215:chronic_disease,216:233:chronic_disease
|
Subjects with any known uncontrolled inter-current illness including ongoing or active infections, symptomatic congestive heart failure (NYHA>2), unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"Subjects",
"with",
"any",
"known",
"uncontrolled",
"inter-current",
"illness",
"including",
"ongoing",
"or",
"active",
"infections",
",",
"symptomatic",
"congestive",
"heart",
"failure",
"(",
"NYHA",
">",
"2",
")",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02243813
|
33:51:treatment,
|
Agree to refrain from using any psychoactive drugs, including alcoholic beverages and nicotine, 24 hours before and after each drug administration
| 1
|
[
"Agree",
"to",
"refrain",
"from",
"using",
"any",
"psychoactive",
"drugs",
",",
"including",
"alcoholic",
"beverages",
"and",
"nicotine",
",",
"24",
"hours",
"before",
"and",
"after",
"each",
"drug",
"administration"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02772562
|
14:22:chronic_disease
|
Uncontrolled diabetes
| 1
|
[
"Uncontrolled",
"diabetes"
] |
[
0,
2
] |
NCT03088709
|
13:24:treatment
|
(except for hydroxyurea)
| 1
|
[
"(",
"except",
"for",
"hydroxyurea",
")"
] |
[
0,
0,
0,
1,
0
] |
NCT03090607
|
48:75:chronic_disease,87:104:chronic_disease,106:119:treatment,138:146:chronic_disease,150:169:chronic_disease
|
Has a condition that could lead to significant postoperative complications, including current infection, anticoagulant use, uncontrolled diabetes or autoimmune disorder
| 1
|
[
"Has",
"a",
"condition",
"that",
"could",
"lead",
"to",
"significant",
"postoperative",
"complications",
",",
"including",
"current",
"infection",
",",
"anticoagulant",
"use",
",",
"uncontrolled",
"diabetes",
"or",
"autoimmune",
"disorder"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
1,
0,
0,
0,
2,
0,
2,
2
] |
NCT02131467
|
8:17:chronic_disease
|
Active psychosis
| 1
|
[
"Active",
"psychosis"
] |
[
0,
2
] |
NCT03075826
|
1:34:chronic_disease,66:75:chronic_disease,77:113:chronic_disease,115:139:chronic_disease,141:159:chronic_disease,164:201:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to, infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01912612
|
26:65:treatment,70:95:treatment,105:114:treatment
|
Willing to withdraw from selective serotonin reuptake inhibitors and tricyclic antidepressants prior to treatment initiation
| 1
|
[
"Willing",
"to",
"withdraw",
"from",
"selective",
"serotonin",
"reuptake",
"inhibitors",
"and",
"tricyclic",
"antidepressants",
"prior",
"to",
"treatment",
"initiation"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
0,
1,
1,
0,
0,
1,
0
] |
NCT01422005
|
10:30:chronic_disease,39:50:chronic_disease,58:64:chronic_disease,66:74:chronic_disease,79:100:chronic_disease
|
Previous neurological illness such as head trauma, prior stroke, epilepsy, or demyelinating disease
| 1
|
[
"Previous",
"neurological",
"illness",
"such",
"as",
"head",
"trauma",
",",
"prior",
"stroke",
",",
"epilepsy",
",",
"or",
"demyelinating",
"disease"
] |
[
0,
2,
2,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT02387905
|
30:38:cancer,40:47:cancer,52:74:cancer
|
Patients with a histology of lymphoma, myeloma and small cell lung cancer histologies
| 1
|
[
"Patients",
"with",
"a",
"histology",
"of",
"lymphoma",
",",
"myeloma",
"and",
"small",
"cell",
"lung",
"cancer",
"histologies"
] |
[
0,
0,
0,
0,
0,
3,
0,
3,
0,
3,
3,
3,
3,
0
] |
NCT02425904
|
76:92:chronic_disease,106:130:chronic_disease,132:147:chronic_disease,158:176:chronic_disease,181:200:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01853163
|
35:49:treatment
|
0.025 mmol per kg body weight for Gadoxetic acid and 0.1 mmol per kg body weight for all other agents
| 1
|
[
"0.025",
"mmol",
"per",
"kg",
"body",
"weight",
"for",
"Gadoxetic",
"acid",
"and",
"0.1",
"mmol",
"per",
"kg",
"body",
"weight",
"for",
"all",
"other",
"agents"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02309892
|
,75:87:cancer
|
At least 1 site of measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1
| 1
|
[
"At",
"least",
"1",
"site",
"of",
"measurable",
"disease",
"per",
"Response",
"Evaluation",
"Criteria",
"in",
"Solid",
"Tumors",
"(",
"RECIST",
")",
"v1.1"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT03084640
|
40:72:treatment
|
currently receiving treatment with the anti-PD-1 antibody pembrolizumab either alone or in combination
| 1
|
[
"currently",
"receiving",
"treatment",
"with",
"the",
"anti-PD-1",
"antibody",
"pembrolizumab",
"either",
"alone",
"or",
"in",
"combination"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03078491
|
8:21:chronic_disease,80:88:chronic_disease,97:114:chronic_disease,123:146:chronic_disease
|
Severe comorbidities that prevent completing outcome measurements (e.g. severe dementia, severe vision impairment, severe functional disabilities, inability to perform basic activities of daily living)
| 1
|
[
"Severe",
"comorbidities",
"that",
"prevent",
"completing",
"outcome",
"measurements",
"(",
"e.g",
".",
"severe",
"dementia",
",",
"severe",
"vision",
"impairment",
",",
"severe",
"functional",
"disabilities",
",",
"inability",
"to",
"perform",
"basic",
"activities",
"of",
"daily",
"living",
")"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02383979
|
36:46:treatment
|
Cooperative, patient scheduled for amputation, with time and availability to do fMRI prior to their operative date
| 1
|
[
"Cooperative",
",",
"patient",
"scheduled",
"for",
"amputation",
",",
"with",
"time",
"and",
"availability",
"to",
"do",
"fMRI",
"prior",
"to",
"their",
"operative",
"date"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02770326
|
9:38:chronic_disease
|
Serious cardiopulmonary comorbidities
| 1
|
[
"Serious",
"cardiopulmonary",
"comorbidities"
] |
[
0,
2,
2
] |
NCT02694029
|
13:37:chronic_disease
|
symptomatic congestive heart failure
| 1
|
[
"symptomatic",
"congestive",
"heart",
"failure"
] |
[
0,
2,
2,
2
] |
NCT02895945
|
1:4:chronic_disease,,
|
HIV+ with stable disease and CD4+ count ≥ 200 cells/mm^3 at screening
| 1
|
[
"HIV+",
"with",
"stable",
"disease",
"and",
"CD4+",
"count",
"≥",
"200",
"cells/mm^3",
"at",
"screening"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03090672
|
13:37:chronic_disease
|
Systemic or psychological impairment which would preclude patient tolerance and understanding of procedures and follow up
| 1
|
[
"Systemic",
"or",
"psychological",
"impairment",
"which",
"would",
"preclude",
"patient",
"tolerance",
"and",
"understanding",
"of",
"procedures",
"and",
"follow",
"up"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02365766
|
15:33:chronic_disease,44:62:treatment,,181:198:treatment,202:226:treatment
|
Has an active autoimmune disease requiring systemic treatment within the past 3 months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents
| 1
|
[
"Has",
"an",
"active",
"autoimmune",
"disease",
"requiring",
"systemic",
"treatment",
"within",
"the",
"past",
"3",
"months",
"or",
"a",
"documented",
"history",
"of",
"clinically",
"severe",
"autoimmune",
"disease",
",",
"or",
"a",
"syndrome",
"that",
"requires",
"systemic",
"steroids",
"or",
"immunosuppressive",
"agents"
] |
[
0,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03058952
|
9:27:chronic_disease
|
Current psychotic disorder
| 1
|
[
"Current",
"psychotic",
"disorder"
] |
[
0,
2,
2
] |
NCT02519322
|
,,,52:61:treatment
|
Amylase < 1.5 X ULN (within 28 days of first study treatment)
| 1
|
[
"Amylase",
"<",
"1.5",
"X",
"ULN",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01422746
|
9:17:treatment,,42:58:chronic_disease,62:83:chronic_disease
|
Morning cortisol < 3 µg/dL or history of Cushing syndrome or adrenal insufficiency
| 1
|
[
"Morning",
"cortisol",
"<",
"3",
"µg/dL",
"or",
"history",
"of",
"Cushing",
"syndrome",
"or",
"adrenal",
"insufficiency"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2
] |
NCT02259621
|
23:44:allergy_name
|
History of allergy to study drug components
| 1
|
[
"History",
"of",
"allergy",
"to",
"study",
"drug",
"components"
] |
[
0,
0,
0,
0,
4,
4,
4
] |
NCT03016351
|
,15:43:treatment
|
more than one anti-hypertensive medication
| 1
|
[
"more",
"than",
"one",
"anti-hypertensive",
"medication"
] |
[
0,
0,
0,
1,
1
] |
NCT02304458
|
47:63:cancer
|
Part B3: patients with relapsed or refractory rhabdomyosarcoma
| 1
|
[
"Part",
"B3",
":",
"patients",
"with",
"relapsed",
"or",
"refractory",
"rhabdomyosarcoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT03011567
|
1:25:chronic_disease
|
Gestational hypertension
| 1
|
[
"Gestational",
"hypertension"
] |
[
2,
2
] |
NCT02762266
|
,40:44:treatment
|
determined from 3 months after initial TACE
| 1
|
[
"determined",
"from",
"3",
"months",
"after",
"initial",
"TACE"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02415556
|
1:25:chronic_disease
|
Serious systemic disease that would interfere with conduction of clinical trial
| 1
|
[
"Serious",
"systemic",
"disease",
"that",
"would",
"interfere",
"with",
"conduction",
"of",
"clinical",
"trial"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03055767
|
1:23:chronic_disease
|
Eaton Lambert Syndrome
| 1
|
[
"Eaton",
"Lambert",
"Syndrome"
] |
[
2,
2,
2
] |
NCT03165227
|
,,,102:109:treatment,111:149:treatment,157:185:treatment
|
Patients with type 1 or type 2 diabetes mellitus, diagnosed before informed consent and treated with insulin, glucagon-like peptide (GLP) 1 agonists and/or oral antidiabetic medication
| 1
|
[
"Patients",
"with",
"type",
"1",
"or",
"type",
"2",
"diabetes",
"mellitus",
",",
"diagnosed",
"before",
"informed",
"consent",
"and",
"treated",
"with",
"insulin",
",",
"glucagon-like",
"peptide",
"(",
"GLP",
")",
"1",
"agonists",
"and/or",
"oral",
"antidiabetic",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1
] |
NCT03051282
|
28:37:allergy_name
|
Subjects hypersensitive to enalapril
| 1
|
[
"Subjects",
"hypersensitive",
"to",
"enalapril"
] |
[
0,
0,
0,
4
] |
NCT02688647
|
1:25:chronic_disease,,
|
Obstructive lung disease: FEV1/ FVC ratio < 0.70
| 1
|
[
"Obstructive",
"lung",
"disease",
":",
"FEV1/",
"FVC",
"ratio",
"<",
"0.70"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02451683
|
39:42:chronic_disease
|
Any debilitating disease prior to the SCI that caused exercise intolerance
| 1
|
[
"Any",
"debilitating",
"disease",
"prior",
"to",
"the",
"SCI",
"that",
"caused",
"exercise",
"intolerance"
] |
[
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02357784
|
16:44:chronic_disease
|
diagnosed with idiopathic dual incontinence
| 1
|
[
"diagnosed",
"with",
"idiopathic",
"dual",
"incontinence"
] |
[
0,
0,
2,
2,
2
] |
NCT02392286
|
6:27:chronic_disease
|
NYHA Class 4 heart failure
| 1
|
[
"NYHA",
"Class",
"4",
"heart",
"failure"
] |
[
0,
2,
2,
2,
2
] |
NCT02803164
|
21:31:cancer
|
Proven or suspected malignancy in the wound
| 1
|
[
"Proven",
"or",
"suspected",
"malignancy",
"in",
"the",
"wound"
] |
[
0,
0,
0,
3,
0,
0,
0
] |
NCT03060096
|
16:33:cancer
|
Diagnosis of a second malignancy
| 1
|
[
"Diagnosis",
"of",
"a",
"second",
"malignancy"
] |
[
0,
0,
0,
3,
3
] |
NCT02926729
|
46:59:cancer
|
Involvement in another therapeutic trial for breast cancer
| 1
|
[
"Involvement",
"in",
"another",
"therapeutic",
"trial",
"for",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT01864265
|
18:32:chronic_disease,60:83:treatment,85:92:treatment,
|
Individuals with claustrophobia, tattoos containing metal, magnetic endoprostheses, surgery on bone in between a time interval < 3 months
| 1
|
[
"Individuals",
"with",
"claustrophobia",
",",
"tattoos",
"containing",
"metal",
",",
"magnetic",
"endoprostheses",
",",
"surgery",
"on",
"bone",
"in",
"between",
"a",
"time",
"interval",
"<",
"3",
"months"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03185130
|
12:37:chronic_disease
|
History of intracranial hypertension
| 1
|
[
"History",
"of",
"intracranial",
"hypertension"
] |
[
0,
0,
2,
2
] |
NCT00492778
|
23:35:treatment
|
Patients who received chemotherapy directed at the present recurrence
| 1
|
[
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"recurrence"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01054196
|
62:70:cancer,72:90:cancer,95:135:cancer
|
Patients must have histologically or cytologically confirmed relapsed, primary refractory, or relapsed and refractory multiple myeloma
| 1
|
[
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"relapsed",
",",
"primary",
"refractory",
",",
"or",
"relapsed",
"and",
"refractory",
"multiple",
"myeloma"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT03011567
|
1:30:chronic_disease,,,
|
Significant liver dysfunction (AST or ALT >500)
| 1
|
[
"Significant",
"liver",
"dysfunction",
"(",
"AST",
"or",
"ALT",
">",
"500",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02007239
|
38:93:treatment
|
On-going or planned participation in another clinical trial involving HLH-directed treatment
| 1
|
[
"On-going",
"or",
"planned",
"participation",
"in",
"another",
"clinical",
"trial",
"involving",
"HLH-directed",
"treatment"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT02359864
|
12:25:chronic_disease
|
History of hydrocephalus
| 1
|
[
"History",
"of",
"hydrocephalus"
] |
[
0,
0,
2
] |
NCT02452008
|
25:47:chronic_disease
|
Have moderate or severe cardiovascular disease
| 1
|
[
"Have",
"moderate",
"or",
"severe",
"cardiovascular",
"disease"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02527265
|
35:41:chronic_disease,76:93:chronic_disease,109:120:treatment
|
History of physician diagnosis of asthma or any other clinically important pulmonary disease, or use of any medications to treat such conditions within the last year
| 1
|
[
"History",
"of",
"physician",
"diagnosis",
"of",
"asthma",
"or",
"any",
"other",
"clinically",
"important",
"pulmonary",
"disease",
",",
"or",
"use",
"of",
"any",
"medications",
"to",
"treat",
"such",
"conditions",
"within",
"the",
"last",
"year"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02845336
|
20:48:chronic_disease
|
Vision loss due to compressive optic neuropathy
| 1
|
[
"Vision",
"loss",
"due",
"to",
"compressive",
"optic",
"neuropathy"
] |
[
0,
0,
0,
0,
2,
2,
2
] |
NCT02927639
|
19:27:chronic_disease,
|
Have been seen in diabetes clinic in the last 6 months
| 1
|
[
"Have",
"been",
"seen",
"in",
"diabetes",
"clinic",
"in",
"the",
"last",
"6",
"months"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT00887146
|
22:65:chronic_disease,22:56:chronic_disease,90:108:treatment
|
Patients known to be human immunodeficiency virus (HIV) positive and currently receiving retroviral therapy
| 1
|
[
"Patients",
"known",
"to",
"be",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive",
"and",
"currently",
"receiving",
"retroviral",
"therapy"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1
] |
NCT01968109
|
36:44:cancer,46:53:cancer,55:62:cancer,67:90:cancer,92:105:cancer,107:114:cancer,119:140:cancer,150:172:treatment,174:191:cancer,183:191:cancer,214:219:cancer,221:241:cancer,251:253:treatment,285:323:treatment,369:439:treatment
|
For Dose escalation: subjects with cervical, ovarian, bladder and colorectal cancer (CRC), head and neck, gastric and hepatocellular cancer naive to immuno-oncology agents; 1st line melanoma and 1st line/2nd line NSCLC; Renal Cell Carcinoma naive to IO; NSCLC progressing while on or after therapy with anti-PD1/anti-PDL-1 and melanoma subjects progressed while-on or after treatment with anti-PD1 or anti-PDL1 with or without anti-CTLA-4
| 1
|
[
"For",
"Dose",
"escalation",
":",
"subjects",
"with",
"cervical",
",",
"ovarian",
",",
"bladder",
"and",
"colorectal",
"cancer",
"(",
"CRC",
")",
",",
"head",
"and",
"neck",
",",
"gastric",
"and",
"hepatocellular",
"cancer",
"naive",
"to",
"immuno-oncology",
"agents",
";",
"1st",
"line",
"melanoma",
"and",
"1st",
"line/2nd",
"line",
"NSCLC",
";",
"Renal",
"Cell",
"Carcinoma",
"naive",
"to",
"IO",
";",
"NSCLC",
"progressing",
"while",
"on",
"or",
"after",
"therapy",
"with",
"anti-PD1/anti-PDL-1",
"and",
"melanoma",
"subjects",
"progressed",
"while-on",
"or",
"after",
"treatment",
"with",
"anti-PD1",
"or",
"anti-PDL1",
"with",
"or",
"without",
"anti-CTLA-4"
] |
[
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
3,
0,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
3,
0,
3,
3,
0,
0,
1,
1,
0,
3,
3,
3,
0,
0,
0,
0,
3,
0,
3,
3,
3,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02533882
|
1:23:chronic_disease,
|
Cardiovascular disease event within the past six months
| 1
|
[
"Cardiovascular",
"disease",
"event",
"within",
"the",
"past",
"six",
"months"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01364363
|
1:4:chronic_disease
|
HIV seronegativity
| 1
|
[
"HIV",
"seronegativity"
] |
[
2,
0
] |
NCT01597518
|
1:12:chronic_disease,,
|
Neutropenia measured as absolute neutrophil count (ANC) measured in cells per microliter of blood of < 1500 at screening visit
| 1
|
[
"Neutropenia",
"measured",
"as",
"absolute",
"neutrophil",
"count",
"(",
"ANC",
")",
"measured",
"in",
"cells",
"per",
"microliter",
"of",
"blood",
"of",
"<",
"1500",
"at",
"screening",
"visit"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03095118
|
1:7:chronic_disease,,
|
Anemia with Hgb < 8.5 g/dL
| 1
|
[
"Anemia",
"with",
"Hgb",
"<",
"8.5",
"g/dL"
] |
[
2,
0,
0,
0,
0,
0
] |
NCT02128230
|
30:40:cancer
|
Patients must not have prior malignancy
| 1
|
[
"Patients",
"must",
"not",
"have",
"prior",
"malignancy"
] |
[
0,
0,
0,
0,
0,
3
] |
NCT02416674
|
12:34:chronic_disease
|
Documented psychological disorder(s) or incomplete psychological clearance
| 1
|
[
"Documented",
"psychological",
"disorder",
"(",
"s",
")",
"or",
"incomplete",
"psychological",
"clearance"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02232516
|
13:37:chronic_disease
|
Symptomatic congestive heart failure
| 1
|
[
"Symptomatic",
"congestive",
"heart",
"failure"
] |
[
0,
2,
2,
2
] |
NCT01811498
|
,,124:133:treatment
|
Patients must agree to use a medically effective method of contraception during and for a period of three months after the treatment period
| 1
|
[
"Patients",
"must",
"agree",
"to",
"use",
"a",
"medically",
"effective",
"method",
"of",
"contraception",
"during",
"and",
"for",
"a",
"period",
"of",
"three",
"months",
"after",
"the",
"treatment",
"period"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01925573
|
58:70:treatment
|
6 weeks since the completion of a nitrosourea-containing chemotherapy regimen
| 1
|
[
"6",
"weeks",
"since",
"the",
"completion",
"of",
"a",
"nitrosourea-containing",
"chemotherapy",
"regimen"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT03143153
|
49:65:chronic_disease
|
Any serious or uncontrolled medical disorder or active infection
| 1
|
[
"Any",
"serious",
"or",
"uncontrolled",
"medical",
"disorder",
"or",
"active",
"infection"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03019133
|
1:44:treatment
|
Ventilator support via an endotracheal tube
| 1
|
[
"Ventilator",
"support",
"via",
"an",
"endotracheal",
"tube"
] |
[
1,
1,
1,
1,
1,
1
] |
NCT03113825
|
1:40:treatment
|
Radiation therapy to ipsilateral breast [Period 1]
| 1
|
[
"Radiation",
"therapy",
"to",
"ipsilateral",
"breast",
"[",
"Period",
"1",
"]"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
0
] |
NCT02053246
|
9:25:chronic_disease
|
Primary valvular disease
| 1
|
[
"Primary",
"valvular",
"disease"
] |
[
0,
2,
2
] |
NCT02282462
|
12:35:treatment,40:55:chronic_disease,57:69:chronic_disease,73:87:chronic_disease
|
undergoing anatomic lung resection for bullous disease, lung abscess or bronchiectasis
| 1
|
[
"undergoing",
"anatomic",
"lung",
"resection",
"for",
"bullous",
"disease",
",",
"lung",
"abscess",
"or",
"bronchiectasis"
] |
[
0,
1,
2,
2,
0,
2,
2,
0,
0,
0,
0,
2
] |
NCT03152058
|
12:31:chronic_disease,39:59:chronic_disease,64:87:chronic_disease
|
History of recurrent infection, e.g., recurrent cellulitis, or opportunistic infection
| 1
|
[
"History",
"of",
"recurrent",
"infection",
",",
"e.g.",
",",
"recurrent",
"cellulitis",
",",
"or",
"opportunistic",
"infection"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01722240
|
1:16:chronic_disease,44:60:treatment,82:94:treatment
|
Type 1 Diabetes on continuous subcutaneous insulin infusion (CSII; also known as insulin pump)
| 1
|
[
"Type",
"1",
"Diabetes",
"on",
"continuous",
"subcutaneous",
"insulin",
"infusion",
"(",
"CSII",
";",
"also",
"known",
"as",
"insulin",
"pump",
")"
] |
[
2,
2,
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01817751
|
,,,117:126:treatment
|
Any other hemorrhage/bleeding event >= grade 3 (NCI CTCAE v4.0) within 4 weeks or less prior to first dose of study treatment
| 1
|
[
"Any",
"other",
"hemorrhage/bleeding",
"event",
">",
"=",
"grade",
"3",
"(",
"NCI",
"CTCAE",
"v4.0",
")",
"within",
"4",
"weeks",
"or",
"less",
"prior",
"to",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02496663
|
96:105:treatment,107:118:treatment,122:140:treatment,172:178:treatment,
|
Patients currently receiving (or unable to stop use prior to receiving the first dose of study treatment) medications or herbal supplements known to be potent inducers of CYP3A4 (at least 3 weeks prior)
| 1
|
[
"Patients",
"currently",
"receiving",
"(",
"or",
"unable",
"to",
"stop",
"use",
"prior",
"to",
"receiving",
"the",
"first",
"dose",
"of",
"study",
"treatment",
")",
"medications",
"or",
"herbal",
"supplements",
"known",
"to",
"be",
"potent",
"inducers",
"of",
"CYP3A4",
"(",
"at",
"least",
"3",
"weeks",
"prior",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02385110
|
85:88:chronic_disease
|
It must be noted that no diagnostic criteria have been established for diagnosis of HLH in adult patients as this was a hitherto poorly identified and considered to be a very rare disease in adults
| 1
|
[
"It",
"must",
"be",
"noted",
"that",
"no",
"diagnostic",
"criteria",
"have",
"been",
"established",
"for",
"diagnosis",
"of",
"HLH",
"in",
"adult",
"patients",
"as",
"this",
"was",
"a",
"hitherto",
"poorly",
"identified",
"and",
"considered",
"to",
"be",
"a",
"very",
"rare",
"disease",
"in",
"adults"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02089607
|
24:40:chronic_disease
|
Patients with ruptured aortic aneurysms requiring urgent or emergent repair, with the exception of patients with contained, stable ruptures with anatomy suitable for an off-the-shelf design
| 1
|
[
"Patients",
"with",
"ruptured",
"aortic",
"aneurysms",
"requiring",
"urgent",
"or",
"emergent",
"repair",
",",
"with",
"the",
"exception",
"of",
"patients",
"with",
"contained",
",",
"stable",
"ruptures",
"with",
"anatomy",
"suitable",
"for",
"an",
"off-the-shelf",
"design"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02133196
|
1:27:chronic_disease,45:69:treatment,72:93:chronic_disease,137:154:chronic_disease
|
Active systemic infections (e.g.: requiring anti-infective treatment), coagulation disorders or any other active or uncompensated major medical illnesses
| 1
|
[
"Active",
"systemic",
"infections",
"(",
"e.g",
".",
":",
"requiring",
"anti-infective",
"treatment",
")",
",",
"coagulation",
"disorders",
"or",
"any",
"other",
"active",
"or",
"uncompensated",
"major",
"medical",
"illnesses"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02290951
|
16:50:chronic_disease,54:71:chronic_disease,77:100:chronic_disease,104:127:chronic_disease
|
Infection with human immunodeficiency virus (HIV) or chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV)
| 1
|
[
"Infection",
"with",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"chronic",
"infection",
"with",
"hepatitis",
"B",
"virus",
"(",
"HBV",
")",
"or",
"hepatitis",
"C",
"virus",
"(",
"HCV",
")"
] |
[
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02600026
|
1:20:chronic_disease
|
language impairment that would interfere with the ability to participate in the educational intervention
| 1
|
[
"language",
"impairment",
"that",
"would",
"interfere",
"with",
"the",
"ability",
"to",
"participate",
"in",
"the",
"educational",
"intervention"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01859819
|
13:25:treatment
|
No previous chemotherapy
| 1
|
[
"No",
"previous",
"chemotherapy"
] |
[
0,
0,
1
] |
NCT02805504
|
8:22:chronic_disease,24:31:chronic_disease,33:46:chronic_disease,50:73:chronic_disease
|
Severe cardiovascular, hepatic, renal disease or neurological impairment
| 1
|
[
"Severe",
"cardiovascular",
",",
"hepatic",
",",
"renal",
"disease",
"or",
"neurological",
"impairment"
] |
[
0,
2,
0,
2,
0,
2,
2,
0,
2,
2
] |
NCT02693990
|
30:59:chronic_disease
|
Patients may or may not have neurofibromatosis type 1 or 2
| 1
|
[
"Patients",
"may",
"or",
"may",
"not",
"have",
"neurofibromatosis",
"type",
"1",
"or",
"2"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02424968
|
72:82:treatment
|
Must be an HLA-matched or single allele mismatched sibling of enrolled transplant patient
| 1
|
[
"Must",
"be",
"an",
"HLA-matched",
"or",
"single",
"allele",
"mismatched",
"sibling",
"of",
"enrolled",
"transplant",
"patient"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02680535
|
1:25:cancer
|
seminal vesicle invasion
| 1
|
[
"seminal",
"vesicle",
"invasion"
] |
[
3,
3,
3
] |
NCT02680535
|
10:33:treatment,
|
received investigational therapy within a period of 5 half-lives of the investigational therapy in question prior to the day of dosing with the PEGylated AuroShell particles
| 1
|
[
"received",
"investigational",
"therapy",
"within",
"a",
"period",
"of",
"5",
"half-lives",
"of",
"the",
"investigational",
"therapy",
"in",
"question",
"prior",
"to",
"the",
"day",
"of",
"dosing",
"with",
"the",
"PEGylated",
"AuroShell",
"particles"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02091999
|
14:47:cancer
|
Uncontrolled central nervous system metastases
| 1
|
[
"Uncontrolled",
"central",
"nervous",
"system",
"metastases"
] |
[
0,
3,
3,
3,
3
] |
NCT02442297
|
25:81:cancer,71:74:cancer,85:115:cancer
|
Recurrent or refractory HER2 positive primary central nervous system (CNS) tumor or HER2 positive tumor metastatic to the CNS
| 1
|
[
"Recurrent",
"or",
"refractory",
"HER2",
"positive",
"primary",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"tumor",
"or",
"HER2",
"positive",
"tumor",
"metastatic",
"to",
"the",
"CNS"
] |
[
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01954173
|
15:25:cancer
|
Patients with metastatic disease outside of the pelvis
| 1
|
[
"Patients",
"with",
"metastatic",
"disease",
"outside",
"of",
"the",
"pelvis"
] |
[
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT00383656
|
11:49:treatment
|
receiving physiologic glucocorticoid replacement if needed
| 1
|
[
"receiving",
"physiologic",
"glucocorticoid",
"replacement",
"if",
"needed"
] |
[
0,
1,
1,
1,
0,
0
] |
NCT03129880
|
18:32:chronic_disease
|
Diagnosed with a Voice disorder
| 1
|
[
"Diagnosed",
"with",
"a",
"Voice",
"disorder"
] |
[
0,
0,
0,
2,
2
] |
NCT02778282
|
20:28:chronic_disease
|
DSM-V diagnosis of dementia
| 1
|
[
"DSM-V",
"diagnosis",
"of",
"dementia"
] |
[
0,
0,
0,
2
] |
NCT02624258
|
23:38:allergy_name
|
History of allergy to murine proteins
| 1
|
[
"History",
"of",
"allergy",
"to",
"murine",
"proteins"
] |
[
0,
0,
0,
0,
4,
4
] |
NCT01660607
|
18:21:chronic_disease
|
Seronegative for HIV 1 RNA (polymerase chair reaction (PCR)
| 1
|
[
"Seronegative",
"for",
"HIV",
"1",
"RNA",
"(",
"polymerase",
"chair",
"reaction",
"(",
"PCR",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562716
|
,,,151:163:treatment
|
women/men of reproductive potential must have agreed to use an effective contraceptive method for up to 3 months after the final administered dose of chemotherapy
| 1
|
[
"women/men",
"of",
"reproductive",
"potential",
"must",
"have",
"agreed",
"to",
"use",
"an",
"effective",
"contraceptive",
"method",
"for",
"up",
"to",
"3",
"months",
"after",
"the",
"final",
"administered",
"dose",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02541955
|
36:60:treatment,,103:113:treatment,122:136:treatment
|
Subjects who have received live or live attenuated vaccines within 6 weeks prior to the first dose of study drug (or the zoster vaccine)
| 1
|
[
"Subjects",
"who",
"have",
"received",
"live",
"or",
"live",
"attenuated",
"vaccines",
"within",
"6",
"weeks",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drug",
"(",
"or",
"the",
"zoster",
"vaccine",
")"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0
] |
NCT02145351
|
8:31:treatment,
|
Stable cardiac medical therapy for ≥30 days
| 1
|
[
"Stable",
"cardiac",
"medical",
"therapy",
"for",
"≥30",
"days"
] |
[
0,
1,
1,
1,
0,
0,
0
] |
NCT02374021
|
1:22:chronic_disease
|
demyelinating disease
| 1
|
[
"demyelinating",
"disease"
] |
[
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.